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 Oral lichen planus (OLP) is considered as a potentially malignant disorder and 
vascular endothelial growth factor (VEGF) may play a key role in cancer development. The aim of 
this study was to compare serum and saliva VEGF among patients with OLP, oral squamous cell 
carcinoma (OSCC) and a healthy control group.  
 A cross sectional study was performed on 27 patients with OLP, 27 patients with OSCC 
and 27 healthy volunteers. The serum and saliva VEGF were assayed by ELISA method. Statistical 
analysis of ANOVA was used.  
 The mean saliva flow rate and serum VEGF in OLP and OSCC patients were significantly 
lower compared to healthy control group (p<0.05), but there was no significant difference between 
OLP and OSCC patients. There was no significant difference in mean salivary VEGF among 
groups. 
 It seems that saliva VEGF may not be a good biomarker for OLP and OSCC.  
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Table 1. Serum and saliva levels of VEGF and total protein in OLP, OSCC and healthy control groups 
 Healthy control OLP OSCC 
Sex (Male/Female) 9/18 9/18 12/15 
Age (mean (range)) 41.7 (31-64) 52 (25-77)* 65 (35-83)*# 
Unstimulated saliva flow rate (mL/min) 0.78 ± 0.09 0.43 ± 0.05* 0.40 ± 0.06* 
Stimulated saliva flow rate (mL/min) 0.91 ± 0.12 0.62 ± 0.07* 0.50 ± 0.06* 
Serum VEGF (ng/mL) 0.29 ± 0.05 0.16 ± 0.02* 0.20 ± 0.03* 
Unstimulated saliva VEGF (ng/mL) 4.59 ± 0.57 3.26 ± 0.43 3.50 ± 0.46 
Stimulated saliva VEGF (ng/mL) 1.94 ± 0.20 1.60 ± 0.13 2.20 ± 0.28 
Data are expressed as mean ± SEM, *: Different from control group, P < 0.05, #: Different from OLP groups, p<0.05 
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